ATRYS HEALTH Valuation
| A2T Stock | EUR 2.96 0.07 2.42% |
Based on Macroaxis valuation methodology, the firm appears to be overvalued. ATRYS HEALTH SA shows a prevailing Real Value of €2.46 per share. The current price of the firm is €2.96. Our model approximates the value of ATRYS HEALTH SA from analyzing the firm fundamentals such as cash and equivalents of 17.6 M, and EBITDA of 6.68 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that ATRYS HEALTH's price fluctuation is relatively risky at this time. Calculation of the real value of ATRYS HEALTH SA is based on 3 months time horizon. Increasing ATRYS HEALTH's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the ATRYS stock is determined by what a typical buyer is willing to pay for full or partial control of ATRYS HEALTH SA. Since ATRYS HEALTH is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ATRYS Stock. However, ATRYS HEALTH's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.96 | Real 2.46 | Hype 2.96 | Naive 2.9 |
The real value of ATRYS Stock, also known as its intrinsic value, is the underlying worth of ATRYS HEALTH SA Company, which is reflected in its stock price. It is based on ATRYS HEALTH's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of ATRYS HEALTH's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of ATRYS HEALTH SA helps investors to forecast how ATRYS stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ATRYS HEALTH more accurately as focusing exclusively on ATRYS HEALTH's fundamentals will not take into account other important factors: ATRYS HEALTH Total Value Analysis
ATRYS HEALTH SA is presently estimated to have takeover price of 0 with market capitalization of 330.53 M, debt of 71.4 M, and cash on hands of 17.6 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the ATRYS HEALTH fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
0 | 330.53 M | 71.4 M | 17.6 M |
ATRYS HEALTH Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of ATRYS implies not a very effective usage of assets in November.ATRYS HEALTH Profitability Analysis
Net Loss for the year was (2.02 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates ATRYS HEALTH's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in ATRYS HEALTH and how it compares across the competition.
About ATRYS HEALTH Valuation
The stock valuation mechanism determines ATRYS HEALTH's current worth on a weekly basis. Our valuation model uses a comparative analysis of ATRYS HEALTH. We calculate exposure to ATRYS HEALTH's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of ATRYS HEALTH's related companies.Atrys Health, S.A., a biomedical company, provides diagnostic services and medical treatments. Atrys Health, S.A. was incorporated in 2007 and is headquartered in Madrid, Spain. ATRYS HEALTH is traded on Frankfurt Stock Exchange in Germany.
8 Steps to conduct ATRYS HEALTH's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates ATRYS HEALTH's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct ATRYS HEALTH's valuation analysis, follow these 8 steps:- Gather financial information: Obtain ATRYS HEALTH's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine ATRYS HEALTH's revenue streams: Identify ATRYS HEALTH's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research ATRYS HEALTH's industry and market trends, including the size of the market, growth rate, and competition.
- Establish ATRYS HEALTH's growth potential: Evaluate ATRYS HEALTH's management, business model, and growth potential.
- Determine ATRYS HEALTH's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate ATRYS HEALTH's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for ATRYS Stock analysis
When running ATRYS HEALTH's price analysis, check to measure ATRYS HEALTH's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ATRYS HEALTH is operating at the current time. Most of ATRYS HEALTH's value examination focuses on studying past and present price action to predict the probability of ATRYS HEALTH's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ATRYS HEALTH's price. Additionally, you may evaluate how the addition of ATRYS HEALTH to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |